Work

A phase II study of intermittent sunitinib (S) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.4515

Authors: Brian I. Rini, Laura S. Wood, Paul Elson, Hui Zhu, Namita Chittoria, Kriti Mittal, Robert Dreicer, Timothy D. Gilligan, Shetal N. Shah, Jorge A. Garcia

Institution: Cleveland Clinic

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4243559075

Cites:

Cited by: 10

Related to: 10